Related Experiment Video
Updated: May 23, 2025
In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
Published on: May 24, 2020
Effects of Common Anticoagulants on the Visual Characteristics of Bloodstains
Zun-Lei Qian1,2, Meng-Qi Wu3, Yu Shi4
1School of Investigation, People's Public Security University of China, Beijing 100038, China.
Objectives:
To investigate the effects of three common anticoagulants, ethylene diamine tetraacetic acid-K2 (EDTA-K2), sodium citrate and heparin sodium, on the visual characteristics of bloodstains such as patterns and colors.
Methods:
Freshly collected blood samples were treated with EDTA-K2, sodium citrate and heparin sodium respectively, and bloodstain samples were prepared on two objects, acrylic plate and ceramic tile. Bloodstains without anticoagulant treatment were used as the control sample. The drying time, wetting ratio, the number of cracks, the number of fragments, the central impression area ratio and the mean gray value of bloodstains were observed and recorded.
Results:
Anticoagulants delayed the drying process of bloodstains. At 3.5 h, the wetting ratios of EDTA-K2-, sodium citrate- and heparin sodium-anticoagulated bloodstains on the acrylic plate were 54.80%, 56.68% and 60.60%, respectively, which were higher than that of bloodstains without anticoagulant treatment (25.70%). Anticoagulants increased the number of cracks, the number of fragments and the central impression area ratio. The changes of these three visual characteristics were most obvious in the sodium citrate-anticoagulated bloodstains, with the crack number of 0.93/mm, the fragment number of 46, and the central impression area ratio of 48.41% after drying. Anticoagulants reduced the mean gray value of bloodstains. Among them, the sodium citrate-anticoagulated bloodstains exhibited the longest time to peak in mean gray value, reading 3.5 h. Similar changes in visual characteristics were observed on the ceramic tile.
Conclusions:
The three commonly used anticoagulants change the visual characteristics of bloodstains. It is not recommended to use anticoagulated blood as a substitute for preparing experimental samples in bloodstain pattern analysis experiments. Based on the changes in the visual characteristics during the drying process of bloodstains, the time of bloodstain deposition can be roughly estimated, and the blood scene staged with anticoagulated blood can be identified.
Related Concept Videos
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
01:24Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:20Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
01:05Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
01:09Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...